Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Psychotherapy and Psychosomatics
|
January 25, 2024
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression
Taeho Greg Rhee, Sung Ryul Shim, Kevin J Manning, et al.
JAMA Psychiatry
|
May 6, 2026
Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis
Sung Ryul Shim, Hye Su Jeong, Tanner J Bommersbach, et al.
The American Journal of Psychiatry
|
February 16, 2019
Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study
Tyler S Kaster, Jonathan Downar, Fidel Vila-Rodriguez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 24, 2024
Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy
Michelle S Goodman, Alisson P Trevizol, Gerasimos N Konstantinou, et al.
Journal of Affective Disorders
|
January 25, 2026
Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modeling
Reinhard Janssen-Aguilar, Jithin Joseph, Huda Al-Shamali, et al.
BMC Psychiatry
|
January 8, 2024
A randomized sham-controlled trial of high-dosage accelerated intermittent theta burst rTMS in major depression: study protocol
Michelle S Goodman, Fidel Vila-Rodriguez, Melanie Barwick, et al.
The Lancet. Psychiatry
|
April 17, 2026
Confirmatory efficacy and safety trial of magnetic seizure therapy versus right unilateral ultra-brief electroconvulsive therapy in depression (CREST-MST): a randomised, double-blind, non-inferiority trial in Canada and the USA
Daniel M Blumberger, Shawn M McClintock, Kevin E Thorpe, et al.
Psychiatry Research
|
June 9, 2026
Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world setting
Reinhard Janssen-Aguilar, Jithin Joseph, Huda F Al-Shamali, et al.
The American Journal of Psychiatry
|
May 6, 2026
Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial
Daniel M Blumberger, Fidel Vila Rodriguez, Shawn M McClintock, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
Orly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Psychotherapy and Psychosomatics
|
January 25, 2024
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression
Taeho Greg Rhee, Sung Ryul Shim, Kevin J Manning, et al.
JAMA Psychiatry
|
May 6, 2026
Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis
Sung Ryul Shim, Hye Su Jeong, Tanner J Bommersbach, et al.
The American Journal of Psychiatry
|
February 16, 2019
Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study
Tyler S Kaster, Jonathan Downar, Fidel Vila-Rodriguez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 24, 2024
Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy
Michelle S Goodman, Alisson P Trevizol, Gerasimos N Konstantinou, et al.
Journal of Affective Disorders
|
January 25, 2026
Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modeling
Reinhard Janssen-Aguilar, Jithin Joseph, Huda Al-Shamali, et al.
BMC Psychiatry
|
January 8, 2024
A randomized sham-controlled trial of high-dosage accelerated intermittent theta burst rTMS in major depression: study protocol
Michelle S Goodman, Fidel Vila-Rodriguez, Melanie Barwick, et al.
The Lancet. Psychiatry
|
April 17, 2026
Confirmatory efficacy and safety trial of magnetic seizure therapy versus right unilateral ultra-brief electroconvulsive therapy in depression (CREST-MST): a randomised, double-blind, non-inferiority trial in Canada and the USA
Daniel M Blumberger, Shawn M McClintock, Kevin E Thorpe, et al.
Psychiatry Research
|
June 9, 2026
Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world setting
Reinhard Janssen-Aguilar, Jithin Joseph, Huda F Al-Shamali, et al.
The American Journal of Psychiatry
|
May 6, 2026
Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial
Daniel M Blumberger, Fidel Vila Rodriguez, Shawn M McClintock, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
Orly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Page
of 5